The latest quarterly R&D expense is $0 with a QoQ Growth of -100.00%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.
Q2 FY2026 (2026-06-30).
Reported quarterly R&D expense; no daily interpolation. Q2 FY2026 (2026-06-30): $0.00.
$0
$0
Q2 FY2026 · 2026-06-30
-100.00%
vs. $49.00M prior quarter
12
Quarters of data available
| Period | R&D Expense | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2026Period end 2026-06-30 | $0 | -100.00% | -100.00% |
| Q1 FY2026Period end 2026-03-31 | $49.00M | -5.77% | -73.08% |
| Q4 FY2025Period end 2025-12-31 | $52.00M | -1.89% | -58.06% |
| Q3 FY2025Period end 2025-09-30 | $53.00M | -7.02% | -66.03% |
| Q2 FY2025Period end 2025-06-30 | $57.00M | -68.68% | -67.24% |
| Q1 FY2025Period end 2025-03-31 | $182.00M | +46.77% | +0.55% |
| Q4 FY2024Period end 2024-12-31 | $124.00M | -20.51% | -25.30% |
| Q3 FY2024Period end 2024-09-30 | $156.00M | -10.34% | +9.86% |
| Q2 FY2024Period end 2024-06-30 | $174.00M | -3.87% | N/A |
| Q1 FY2024Period end 2024-03-30 | $181.00M | +9.04% | N/A |
| Q4 FY2023Period end 2023-12-31 | $166.00M | +16.90% | N/A |
| Q3 FY2023Period end 2023-09-30 | $142.00M | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.
